Trial Profile
Multicentre open-label study of neurotransmitters and neuropeptides in schizophrenia: a multidisciplinary study of biological, pharmacokinetic, receptor occupancy and clinical relationships in patients suffering from schizophrenia treated with quetiapine (Seroquel).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Oct 2012
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Schizophrenia
- Focus Biomarker; Pharmacodynamics; Pharmacogenomic
- 23 Jan 2010 New trial record